Amiodarone versus Sotalol for Atrial Fibrillation
Top Cited Papers
- 5 May 2005
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 352 (18), 1861-1872
- https://doi.org/10.1056/nejmoa041705
Abstract
The optimal pharmacologic means to restore and maintain sinus rhythm in patients with atrial fibrillation remains controversial.Keywords
This publication has 39 references indexed in Scilit:
- Atrial Fibrillation: Epidemiologic Considerations and Rationale for Conversion and Maintenance of Sinus RhythmJournal of Cardiovascular Pharmacology and Therapeutics, 2003
- A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial FibrillationNew England Journal of Medicine, 2002
- A Comparison of Rate Control and Rhythm Control in Patients with Atrial FibrillationNew England Journal of Medicine, 2002
- Atrial fibrillationAmerican Journal Of Medicine, 2002
- Atrial Fibrillation Following Investigation of Rhythm Management: AFFIRM Trial Outcomes. What Might Be Their Implications for Arrhythmia Control?Journal of Cardiovascular Pharmacology and Therapeutics, 2002
- Prevalence of Diagnosed Atrial Fibrillation in AdultsJAMA, 2001
- Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trialThe Lancet, 2000
- Management of Patients With Atrial FibrillationCirculation, 1996
- The effect of amiodarone, a new anti‐anginal drug, on cardiac muscleBritish Journal of Pharmacology, 1970
- A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474British Journal of Pharmacology, 1970